Sheila Anne Denton
About Sheila Anne Denton
Sheila A. Denton, J.D., serves as the Executive Vice President and General Counsel at Incyte, bringing over 30 years of experience in legal, policy, and compliance within the biopharmaceutical sector.
Sheila A. Denton's Role at Incyte
Sheila A. Denton, J.D., joined Incyte in 2023 as the Executive Vice President and General Counsel. In this role, she leverages her extensive experience in legal, policy, and compliance to oversee and guide the company’s legal strategies. Denton’s broad expertise helps Incyte navigate the complex regulatory landscape in the biopharmaceutical sector.
Legal and Compliance Experience
With over 30 years of experience, Sheila A. Denton has a deep background in legal, policy, and compliance matters, particularly within the biopharmaceutical, pharmaceutical, and animal health industries. Her comprehensive understanding of these domains enables her to deliver strategic legal guidance and ensure compliance with industry regulations. Her experience spans critical areas necessary for legal and policy functions within these sectors.
Career at Boehringer Ingelheim
Sheila A. Denton spent nearly 20 years at Boehringer Ingelheim, where she held the position of Senior Vice President, General Counsel, and Corporate Secretary. In this key role, she led a team of professionals across various functions including legal, compliance, governmental affairs, and policy. Denton was instrumental in providing solution-oriented support for both the pharmaceutical and animal health businesses, guiding them through complex legal and regulatory issues.
Leadership Responsibilities
During her tenure at Boehringer Ingelheim, Sheila A. Denton’s responsibilities encompassed leading a multidisciplinary team of professionals. Her leadership extended across legal, compliance, governmental affairs, and policy functions. She successfully directed efforts to provide strategic, solution-oriented support aimed at fostering the growth and compliance of the company’s pharmaceutical and animal health units.